| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3652878
[patent_doc_number] => 05658565
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'Inducible nitric oxide synthase gene for treatment of disease'
[patent_app_type] => 1
[patent_app_number] => 8/265046
[patent_app_country] => US
[patent_app_date] => 1994-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18913
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/658/05658565.pdf
[firstpage_image] =>[orig_patent_app_number] => 265046
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/265046 | Inducible nitric oxide synthase gene for treatment of disease | Jun 23, 1994 | Issued |
Array
(
[id] => 3658984
[patent_doc_number] => 05623065
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'Gapped 2\' modified oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/244993
[patent_app_country] => US
[patent_app_date] => 1994-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14126
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/623/05623065.pdf
[firstpage_image] =>[orig_patent_app_number] => 244993
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/244993 | Gapped 2' modified oligonucleotides | Jun 20, 1994 | Issued |
Array
(
[id] => 3509299
[patent_doc_number] => 05563064
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-08
[patent_title] => 'Process for preparing daunorubicin'
[patent_app_type] => 1
[patent_app_number] => 8/259924
[patent_app_country] => US
[patent_app_date] => 1994-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5025
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/563/05563064.pdf
[firstpage_image] =>[orig_patent_app_number] => 259924
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/259924 | Process for preparing daunorubicin | Jun 14, 1994 | Issued |
Array
(
[id] => 3585398
[patent_doc_number] => 05585087
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => 'Assay for identifying extracellular signaling proteins'
[patent_app_type] => 1
[patent_app_number] => 8/255677
[patent_app_country] => US
[patent_app_date] => 1994-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8991
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585087.pdf
[firstpage_image] =>[orig_patent_app_number] => 255677
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/255677 | Assay for identifying extracellular signaling proteins | Jun 7, 1994 | Issued |
Array
(
[id] => 3560253
[patent_doc_number] => 05525467
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-11
[patent_title] => 'Nucleotide sequences'
[patent_app_type] => 1
[patent_app_number] => 8/255889
[patent_app_country] => US
[patent_app_date] => 1994-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 16401
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/525/05525467.pdf
[firstpage_image] =>[orig_patent_app_number] => 255889
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/255889 | Nucleotide sequences | Jun 6, 1994 | Issued |
| 08/254474 | DNA ENCODING FCGAMMAR RECEPTOR PROTEIN ON NK CELLS | Jun 5, 1994 | Abandoned |
| 08/253524 | IDENTIFICATION OF POLYCYSTIC KIDNEY DISEASE GENE, DIAGNOSTICS AND TREATMENT | Jun 2, 1994 | Abandoned |
| 08/252494 | BRANCHED OLIGONUCLEOTIDES AS PATHOGEN-INHIBITORY AGENTS | May 31, 1994 | Abandoned |
| 08/250862 | INHIBITION OF CYTOKINE PRODUCTION BY OLIGONUCLEOTIDES AND INHIBITION OF TUMORS WHICH ARE RESPONSIVE TO CYTOKINE FACTORS | May 30, 1994 | Abandoned |
Array
(
[id] => 3597266
[patent_doc_number] => 05559005
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-24
[patent_title] => 'Bioprocess for preparing 7-ACA and 7-ADAC'
[patent_app_type] => 1
[patent_app_number] => 8/250310
[patent_app_country] => US
[patent_app_date] => 1994-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19658
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/559/05559005.pdf
[firstpage_image] =>[orig_patent_app_number] => 250310
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/250310 | Bioprocess for preparing 7-ACA and 7-ADAC | May 26, 1994 | Issued |
Array
(
[id] => 3447405
[patent_doc_number] => 05424199
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-13
[patent_title] => 'Human growth hormone'
[patent_app_type] => 1
[patent_app_number] => 8/250639
[patent_app_country] => US
[patent_app_date] => 1994-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6277
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/424/05424199.pdf
[firstpage_image] =>[orig_patent_app_number] => 250639
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/250639 | Human growth hormone | May 26, 1994 | Issued |
| 08/248814 | ENHANCING THE SENSITIVITY OF TUMOR CELLS TO THERAPIES | May 23, 1994 | Abandoned |
Array
(
[id] => 3528895
[patent_doc_number] => 05583025
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-10
[patent_title] => 'Enzymes for the production of 2-keto-L-gulonic acid'
[patent_app_type] => 1
[patent_app_number] => 8/249377
[patent_app_country] => US
[patent_app_date] => 1994-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9752
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/583/05583025.pdf
[firstpage_image] =>[orig_patent_app_number] => 249377
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/249377 | Enzymes for the production of 2-keto-L-gulonic acid | May 23, 1994 | Issued |
| 08/197801 | NOVEL HUMAN ENDOTHELIAL CELL-DERIVED POLYPEPTIDES (EDPS), THEIR PRODUCTION AND USES | Apr 28, 1994 | Abandoned |
| 08/237491 | HUMAN ENDOTHELIAL CELL-DERIVED POLYNUCLEOTIDES AND POLYPEPTIDES | Apr 27, 1994 | Abandoned |
Array
(
[id] => 3439319
[patent_doc_number] => 05466448
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-14
[patent_title] => 'Biological control of orthoptera pest insects'
[patent_app_type] => 1
[patent_app_number] => 8/235137
[patent_app_country] => US
[patent_app_date] => 1994-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8465
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/466/05466448.pdf
[firstpage_image] =>[orig_patent_app_number] => 235137
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/235137 | Biological control of orthoptera pest insects | Apr 27, 1994 | Issued |
| 08/227313 | ANAEROBE TARGETED ENZYME-MEDIATED PRODRUG THERAPY | Apr 12, 1994 | Abandoned |
| 08/226072 | DEFECTIVE HERPES AND RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS WITH P53 FOR THE TREATMENT OF CANCER | Apr 10, 1994 | Abandoned |
Array
(
[id] => 3869127
[patent_doc_number] => 05837692
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Inhibition of the mitogenic activity of PDGF by mammalian EGr'
[patent_app_type] => 1
[patent_app_number] => 8/224482
[patent_app_country] => US
[patent_app_date] => 1994-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 8648
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837692.pdf
[firstpage_image] =>[orig_patent_app_number] => 224482
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/224482 | Inhibition of the mitogenic activity of PDGF by mammalian EGr | Apr 6, 1994 | Issued |
Array
(
[id] => 3636016
[patent_doc_number] => 05610289
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-11
[patent_title] => 'Backbone modified oligonucleotide analogues'
[patent_app_type] => 1
[patent_app_number] => 8/150079
[patent_app_country] => US
[patent_app_date] => 1994-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27401
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/610/05610289.pdf
[firstpage_image] =>[orig_patent_app_number] => 150079
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/150079 | Backbone modified oligonucleotide analogues | Apr 6, 1994 | Issued |